↓ Skip to main content

Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, October 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (77th percentile)

Mentioned by

twitter
2 tweeters
patent
1 patent
googleplus
1 Google+ user

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma
Published in
Journal of Experimental & Clinical Cancer Research, October 2013
DOI 10.1186/1756-9966-32-74
Pubmed ID
Authors

Kevin Marley, Stuart C Helfand, Jennifer Simpson, John E Mata, William G Tracewell, Lisa Brownlee, Shay Bracha, Bernard Séguin

Abstract

Osteosarcoma in dogs and humans share many similarities and the dog has been described as an excellent model to study this disease. The median survival in dogs has not improved in the last 25 years. Taurolidine has been shown to be cytotoxic to canine and human osteosarcoma in vitro. The goals of this study were to determine the pharmacokinetics and safety of taurolidine in healthy dogs and the safety of taurolidine in combination with doxorubicin or carboplatin in dogs with osteosarcoma.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 37%
Student > Ph. D. Student 5 17%
Student > Master 4 13%
Student > Postgraduate 3 10%
Other 2 7%
Other 4 13%
Unknown 1 3%
Readers by discipline Count As %
Medicine and Dentistry 11 37%
Veterinary Science and Veterinary Medicine 5 17%
Biochemistry, Genetics and Molecular Biology 3 10%
Pharmacology, Toxicology and Pharmaceutical Science 2 7%
Linguistics 1 3%
Other 4 13%
Unknown 4 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 March 2020.
All research outputs
#4,712,932
of 18,851,697 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#151
of 1,596 outputs
Outputs of similar age
#59,033
of 268,577 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#1
of 1 outputs
Altmetric has tracked 18,851,697 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 1,596 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 268,577 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them